Cover Image
市場調查報告書

HIV·愛滋病檢驗的全球市場

HIV/AIDS Testing

出版商 Global Industry Analysts, Inc. 商品編碼 138757
出版日期 內容資訊 英文 306 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
HIV·愛滋病檢驗的全球市場 HIV/AIDS Testing
出版日期: 2015年10月01日 內容資訊: 英文 306 Pages
簡介

本報告以HIV·愛滋病檢驗的全球市場為焦點,依產品市場區隔 (篩檢檢驗,確認檢驗,監測檢驗) 及地區 (美國,加拿大,日本,歐洲,亞太地區,中南美,其他) 別檢驗·預測2014-2020年這段期間為對象之數量的規模及收益額的轉變,再彙整過去7年的市場過程分析和大小42家參與企業之公司簡介等目前競爭環境相關的調查資訊。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告製作水準
    • 定量技術與分析法
  • 產品的定義和調查範圍
    • 定義

第2章 摘要整理

  • 產業概要
    • HIV·愛滋病檢驗的全球市場 - 分析
    • 地區分析
    • 市場區隔分析
    • 競爭
    • HIV·愛滋病診斷市場參與企業 - 產品矩陣
    • FDA (美國食品藥物管理局) /USAID (美國國際開發署) 核准HIV簡易檢測套組 (2014年)
    • FDA核准HIV-1/2抗體及HIV-1組合式化驗
  • 成長推動要素與市場趨勢
    • 簡易HIV檢驗-廣大的成長性
    • 預防感染擴大的簡易篩檢檢驗
    • 有助於成長的新HIV實驗
    • 病毒數量檢驗趨勢
    • 日益普及的家庭檢驗或自我檢驗
    • 自我檢驗:WHO的配合措施
    • 以自我檢驗為中心的課題
    • DNA-PCR (DNA聚合酵素鏈鎖反應)法
    • 處於開發階段的商業HIV疫苗
    • 臨床實驗(第二階段)中的愛滋病疫苗一覽
    • 在血液篩檢檢驗市場展現強力成長的分子診斷
    • 有助於HIV診斷急救治療室檢驗
    • 促進HIV檢驗急速成長的市售檢測套組
    • 機會指標
    • 持續有助於擴大需求的中年客戶層
    • 女性騎士的增加暗示了今後的商機
  • HIV·愛滋病統計價值
    • 愛滋病 - 全球性蔓延
    • 因子與數值
  • 理解HIV·愛滋病 - 這個病
    • 作用機制
    • 症狀
    • 末期的愛滋病
    • HIV的感染
    • 樂觀面
    • 愛滋病治療
    • 研究仍在持續
    • 軍艦和船隻方法- HIV治療的標的
  • HIV·愛滋病的診斷
    • 檢驗- 愛滋病預防及治療的基本
    • 血液加工
    • 最早的感染發現時期
    • HIV檢驗的課題
    • HIV感染檢驗室診斷的主要缺點
    • 簡易檢驗-適用開發中國家的方法
    • HIV檢驗
    • 遵從嚴格規則的檢驗
    • 診斷測試
    • 分子診斷及遺傳基因檢測產品
    • 技術檢驗
    • 法規
  • 產品認證及銷售
  • 最新產業趨勢
  • 全球主要加入企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 其他歐洲各國
  • 亞太地區
  • 中南美
  • 其他地區

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-3401

This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -

Abbott Laboratories, Inc.
Adaltis S.r.l.
Alere
Beckman Coulter, Inc.
bioMerieux SA

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Definitions
      • HIV/AIDS Screening Tests
      • HIV/AIDS Confirmatory Tests
      • HIV/AIDS Monitoring Tests

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Worldwide HIV/AIDS Testing Market - An Analysis
  • Regional Analysis
  • Segment Analysis
    • HIV/AIDS Screening Tests
    • HIV/AIDS Confirmatory Tests
    • HIV/AIDS Monitoring Market
  • Competition
  • HIV/AIDS Diagnostics Market Participants - Product Matrix
  • FDA/USAID Approved HIV Rapid Test Kits (2014)
  • FDA-Approved Anti-HIV-1/2 and HIV-1 Antigen Combo Assays

2. GROWTH DRIVERS AND MARKET TRENDS

  • Rapid HIV Tests - Vast Growth Potential
  • Rapid Screening Tests Prevent Epidemic Spread
  • New HIV Assays to Fuel Growth
  • Trends in Viral Load Testing
    • Table 1: Viral Load Volumes by Region: Percentage Share of Viral Load Test Volumes for South Africa, Sub-Saharan Africa, and Rest of World (2015, 2017E, & 2019E) (includes corresponding Graph/Chart)
    • Table 2: Viral Load Testing Potential by Setting: Percentage Share of Viral Load Test Volumes for District Hospitals, Large Urban Clinics, and Small Rural Clinics (2015, 2018E, & 2020E) (includes corresponding Graph/Chart)
  • Home Testing or Self-Testing to Gain Strength
  • Self Testing: WHO Initiatives
  • Challenges Involved in Self-Testing
  • DNA-PCR: Preferred Technique for Early Infant Diagnosis (EID)
  • Commercial HIV Vaccines in the Pipeline
  • List of Clinical Trial (Phase II) AIDS Vaccines - 2015
  • Molecular Diagnostics Register Strong Growth in Blood Screening Markets
  • Emergency Room Testing to Help HIV Diagnosis
  • OTC Tests Provide Momentum to HIV Testing

3. HIV/AIDS STATISTICS

  • AIDS: A Global Epidemic
  • Facts & Figures
    • Table 3: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart)
    • Table 4: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart)
    • Table 5: Worldwide AIDS related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart)
    • Table 6: HIV Prevalence (%) in Adults (15-49 years) by Year: Prevalence Percentage in Adults in 1990, 2000, 2008 & 2014 (includes corresponding Graph/Chart)
    • Table 7: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share of Adults who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart)
    • Table 8: HIV Testing Services Availed, by Gender (2014): Percentage Breakdown of Women and Men in all WHO Regions (includes corresponding Graph/Chart)
    • Table 9: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart)
    • Table 10: International & Domestic Spending on ART in Low/Middle-Income Countries, by Region (2013): Expenditure in Millions up to 2013 (includes corresponding Graph/Chart)
    • Table 11: No. of People on Antiviral therapy in Low/Middle-Income Countries, by Region: Numbers in 2012, 2013 & 2014 (includes corresponding Graph/Chart)
    • Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries
  • 4. HIV/AIDS: UNDERSTANDING THE DISEASE
  • Mechanism of Action
  • Symptoms
  • Full-Blown AIDS
  • Transmission of HIV
  • On the Brighter Side
  • HIV Therapy
  • The Search Continues
  • Infection Process - Targets for HIV Therapy
  • 5. DIAGNOSIS OF HIV/AIDS
  • Testing: The Basis for AIDS Prevention and Treatment
  • Blood Processing
  • The Earliest Time to Detect Infection
  • Problems Plaguing HIV Testing
  • Major Drawbacks of Laboratory Diagnosis of HIV Infections
  • Rapid Tests - SuiTable for Developing Countries
  • HIV Tests
  • Testing Subject to Strict Rules
  • Diagnostic Tests
    • I. Antibody Tests
      • A. HIV-1 Screening Tests
      • Test Methodology
      • a. Enzyme-linked Immunosorbent Assays/ Enzyme Immunoassays (ELISA/EIA)
      • b. Home Access HIV-1 test system/Dried Blood Spot
      • c. Rapid Tests
      • B. HIV-1 Antibody Confirmatory Tests
      • a. The Western Blot Test
      • Commonly Used in Developed Countries
      • Interpretation of Results
      • Modified Western Blots
      • b. Indirect Immunofluorescent Antibody Assay (IFA)
      • c. Line Immunoassay
      • d. Radioimmunoprecipitation Assay (RIPA)
      • C. HIV-2 Diagnostic Tests and HIV Group "O
      • Testing Protocols
      • Types of Antibody Tests Based on Sample
      • i. Traditional Blood Antibody Tests
      • ii. Dried Blood Spot (DBS) Sampling Technique
      • iii. Other Alternatives in Samples
      • Oral Testing for HIV
      • Urine Tests
    • II. Viral Identification Assays
      • A. p24 Antigen Test
      • B. Qualitative PCR Tests
      • PCR: The Process
      • C. Viral Culture
    • III. Monitoring Tests
      • A. Lymphocyte Analysis
      • CD4 Cell Counts
      • B. Viral Load Tests
      • Indicator of Successful Therapy
      • Levels of CD4 and Viral Load in AIDS
    • Molecular Diagnostics and Gene Detection Products
      • DNA Probe-Based Products
      • Direct Assays
      • Amplification
      • Amplification Methodologies
      • DNA Chips
      • Growth of DNA Chips Influenced by HIV Research
    • Technology Review
      • Home HIV Tests: Unfolding a New Era of Testing
      • PCR: A Promising Development in HIV/AIDS Monitoring Market
      • DNA Probes are Highly Specific and Sensitive
      • OCA-particles Based Detection System-Offers Increased Accuracy
      • Drawbacks of Blood-Based Tests
    • Regulations
      • Regulatory Overview
      • UN's Testing Policies in Peacekeeping Force
      • Anonymous versus Confidential Diagnostic Testing for HIV infection in US
      • Regulatory Approval for Rapid HIV Test Kits in US
      • HIV Testing - Mandatory in US Blood Banks

6. PRODUCT APPROVALS & LAUNCHES

  • BioPlex(r) 2200 HIV Ag-Ab Assay Receives FDA Pre-market Approval
  • Beckman Coulter Obtains CE Marking for DxN VERIS HIV-1 Assay
  • Chembio Receives CE Mark Approval for its DPP(r) HIV 1/2 Assay
  • BioSure UK Launches HIV Home Testing Kit
  • USFDA Approves cobas(r) TaqScreen MPX Test by Roche Diagnostics
  • Xpert(r) HIV-1 Viral Load Test Acquires CE-IVD Status
  • Hologic Announces CE Mark Certification for its Aptima HIV-1 Quant Dx Assay
  • Bio-Rad's Geenius(tm) HIV 1/2 Supplemental Assay Receives USFDA Pre-market Approval
  • LabCorp Launches HIV GenoSure ArchiveSM Test to Optimize Drug Regimens
  • DiaSorin Launches Liaison XL Murex HIV Ab/Ag High Throughput Test
  • Bio-Rad Launches BioPlex 2200 HIV Ag-Ab Kit for Ex-US Markets
  • MedMira Receives Approval to Market Enhanced Version of Reveal HIV Test in Europe
  • Roche Receives CE Certification to Launch Dual target COBAS Test
  • Theradig and CNRS to Develop Theranostics HIV/AIDS Tests
  • LabCorp Introduces HIV Ag/Ab Combination Assay and Screening Algorithm
  • Alere Launches Rapid POC Determine HIV 1/2 Ag/Ag Combo Test

7. RECENT INDUSTRY ACTIVITY

  • DiaSorin and Beckman Coulter Sign Distribution Partnership Agreement
  • Global Initiative Lowers Price of Infant Early HIV Diagnostic Technologies
  • USAID Project to Deliver HIV Testing Services in Africa
  • Roche to Provide HIV-1 Viral Load and Early Infant Diagnostic Technologies for Global Fund
  • Bio-Rad and Beckman Coulter Extend Distribution Agreement
  • Case Western Reserve University Hospital Signs Agreement with Advanced Biological Laboratories
  • UNAIDS Collaborates with Global Partners to Launch Diagnostics Access Initiative
  • Zyomyx Acquires $7.5 M from WHO to Market MyT4 CD4 Test in Developing World
  • Daktari Diagnostics Seeks Funding for HIV Test Manufacturing Capacity
  • Gilead Sciences and Good Samaritan Foundation Enter Into Partnership to Provide HIV Testing in Africa
  • Chembio Signs Technology License, Distribution & Manufacturing Agreements with RVR Diagnostics SDN BHD
  • Mylan Signs Exclusive Distribution Agreement with Zyomyx for POC CD4 Test
  • Calypte Biomedical and Maxim Sign Joint Distribution Agreement for HIV Tests

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories, Inc. (US)
  • Abbott Molecular, Inc. (US)
  • Adaltis S.r.l. (Italy)
  • Alere (US)
  • Beckman Coulter, Inc. (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories, Inc. (US)
  • Calypte Biomedical Corporation (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • Hologic, Inc. (US)
  • Fujirebio Europe N.V. (Belgium)
  • MedMira Inc. (Canada)
  • OraSure Technologies, Inc. (US)
  • Ortho-Clinical Diagnostics, Inc. (US)
  • Quest Diagnostics, Inc. (US)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics, Inc. (US)
  • Trinity Biotech Plc. (Ireland)

9. GLOBAL MARKET PERSPECTIVE

  • Unit Analytics
    • Table 12: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Dollar Analytics
    • Table 21: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • HIV/AIDS Testing by Test Type
    • Table 24: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Government Mandates and Reimbursement Policies Aid Market Growth
      • List of Key Milestones in HIV Testing & Reimbursement
    • HIV Tests Available in the US Market
      • Anti-HIV-2 Assay (to detect antibodies to Human Immunodeficiency Virus type 2)
      • Anti-HIV-1/2 Assays (to detect antibodies to Human Immunodeficiency Virus types 1 and 2)
      • FDA Approved HIV/AIDS Tests in the US Market: 2015
    • Competitive Structure
    • Table 33: The US HIV POCT Market by Player (2014): Percentage Share of Sales for Chembio, OraSure Blood Tests, Orasure Saliva Tests, and Trinity (includes corresponding Graph/Chart)
    • Rapid HIV Tests Gain Popularity
      • FDA/USAID Approved HIV Rapid Test Kits (2014)
    • Home HIV Tests Abate Privacy Concerns
    • NAT Tests Score High in Blood Banks
    • Major End-Users of HIV/AIDS Tests
    • HIV Testing Made Mandatory in Blood Banks
    • HIV/AIDS Statistics
    • Table 34: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart)
    • Table 35: AIDS Diagnoses in the US by Ethnic Group (Through 2013): Percentage Share of AIDS Diagnosis for Blacks, Asians, Hispanics, Native Hawaiian, Native/American Indians, Whites, and Multiple Races (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Unit Analytics
    • Table 36: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 38: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 39: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 41: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • HIV Statistics
    • Table 42: Age Group Distribution of Reported HIV cases in Canada by Gender: 1985-2013 (includes corresponding Graph/Chart)
    • Table 43: No. of Reported HIV Cases: 2005-2013 (includes corresponding Graph/Chart)
    • Table 44: HIV Cases Reported in Canada by Ethnicity and Mode of Exposure (1998-2013): % Breakdown of Reported HIV cases Among different Ethnic Groups for Men who have sex with Men (MSM), Injection Drug Users (IDU), MSM/IDU, Heterosexuals, and Others (includes corresponding Graph/Chart)
    • Table 45: HIV Diagnosis Rate in Canada by Province: 2013 (includes corresponding raph/Chart)
    • Medmira Inc. - A Key Player
  • B. Market Analytics
    • Unit Analytics
    • Table 46: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 47: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 48: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 49: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 51: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Table 52: HIV Occurrence in Japan by Mode of Transmission (2014): Percentage Share of HIV Transmission by Homosexual Contact, Heterosexual contact, Congenital Transmission, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart)
    • Table 53: AIDS Occurrence in Japan by Mode of Transmission (2014): Percentage Share of AIDS Transmission by Homosexual Contact, Heterosexual contact, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Unit Analytics
    • Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 55: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 56: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 57: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 59: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Regional Analysis
    • Segment Analysis
    • Aids/Hiv Stats - A Review
      • Western Europe
    • Table 60: HIV/AIDS Prevalence in Western Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
      • Central Europe
    • Table 61: HIV/AIDS Prevalence in Central Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
      • Eastern Europe
    • Table 62: HIV/AIDS Prevalence in Eastern Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
    • Regulations
      • Antenatal HIV Testing in Europe
  • B. Market Analytics
    • Unit Analytics
    • Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 65: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 68: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 71: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 72: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 73: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 74: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Pharmacies Start OTC Sales of HIV Home Testing Kits
    • Product Launch
    • BioMerieux SA - A Key Player
  • B. Market Analytics
    • Unit Analytics
    • Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 77: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 78: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 79: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 80: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analysis
    • Unit Analytics
    • Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 82: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 83: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 84: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 85: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 86: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
    • Table 87: HIV/AIDS Prevalence Rates by Age Group in Italy: End of 2011 (includes corresponding Graph/Chart)
    • Product Launch
    • Key Player - Adaltis S.R.L.
  • B. Market Analytics
    • Unit Analytics
    • Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 89: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 90: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 91: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 92: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 93: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • HIV and AIDS Statistics
    • Table 94: HIV Prevalence in the UK by Mode of Transmission (2013): Number of HIV Infections Estimated in MSM, People who Inject Drugs, and Heterosexuals (includes corresponding Graph/Chart)
    • Table 95: HIV Prevalence in the UK in Heterosexuals (2013): Number of HIV Infections Estimated in Heterosexual Men and Women of African Ethnicity and Non-African Ethnicity (includes corresponding Graph/Chart)
    • Table 96: New cases of HIV Diagnoses among Heterosexuals by Age Group (2013): Number of New HIV Infections in Heterosexuals of 15-24, 25-39, 40-49, & 50+ Age Groups (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Unit Analytics
    • Table 97: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 98: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 99: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 100: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 101: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 102: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Unit Analytics
    • Table 103: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 104: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 105: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 106: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 107: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 108: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Ukraine
    • Austria
    • Other European Countries
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Unit Analytics
    • Table 109: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 110: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 111: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 112: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 113: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 114: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • The Next Epicenter for the AIDS Epidemic
    • Table 115: AIDS/HIV Stats in Asia (2014)
    • Review of Select Asian Countries
      • Australia
    • Table 116: Number of HIV and AIDS Cases in Australia: 2005 to 2011 (includes corresponding Graph/Chart)
    • Table 117: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2011 (includes corresponding Graph/Chart)
      • China
      • AIDS/HIV - A Review
      • Efforts to Combat HIV/AIDS
      • India - HIV Concentrated in South and Northeast
    • Table 118: Estimated Living Population in India with HIV/AIDS Infection (2009)
    • Table 119: Prevalence of TB in HIV Patients In India (2010-2013): Total No. of People Attending HIV testing centres, Diagnosed TB cases, and the percentage of HIV-Positive TB patients started on ART (includes corresponding Graph/Chart)
      • Thailand
      • HIV Cases on Decline
    • Table 120: Number of Live Persons Infection with HIV in Thailand, by Category (2011-End): Percentage breakdown of Adult Men & Women, and Children with HIV Infection (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Unit Analytics
    • Table 121: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 122: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 123: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 124: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 125: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 126: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • HIV Epidemic in Latin America
    • Table 127: People Living with HIV Infection in Latin America by Country: 2011 (includes corresponding Graph/Chart)
    • Trends and Transmission Modes
    • Trends in Antiretroviral Treatment
  • B. Market Analytics
    • Unit Analytics
    • Table 128: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 129: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 130: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 131: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 132: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 133: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Africa: Epicenter of the HIV Epidemic
    • Table 134: HIV/AIDS Cases in Africa as of 2011-End: Breakdown by Top 20 Countries (includes corresponding Graph/Chart)
    • Table 135: Adults & Children Deaths Due to AIDS in Africa (2011): Breakdown by Top 10 Countries (includes corresponding Graph/Chart)
    • Sub-Saharan Africa
    • Table 136: AIDS/HIV Stats in Sub-Saharan Africa (2011)
    • Southern Africa
    • East, West and Central Africa
    • South Africa - The HIV/AIDS Hub
    • Uganda - A Review
    • Caribbean Nations
    • Table 137: AIDS/HIV Stats in the Caribbean Nations (2011)
    • Table 138: HIV/AIDS Prevalence in Caribbean Nations: 2014 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Unit Analytics
    • Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 140: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 141: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 142: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 143: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 144: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top